Trial Profile
A Randomized, Double-blind, Multi-center, Phase 2 Trial to Evaluate the Efficacy and Safety of Candesartan/Amlodipine Combined or Alone and Select Better Dose of CKD-330 in Patients With Essential Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary) ; Amlodipine; Candesartan cilexetil
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 21 Jul 2016 Status changed from recruiting to completed.
- 02 Apr 2015 Planned End Date changed from 1 Jan 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record..
- 02 Apr 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.